Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Inhibiting K-ras signaling reserves the epithelial-mesenchymal transition of pancreatic cancer cells and its mechanisms.

Liu XE, Sun XD.

Hepatogastroenterology. 2013 Jul-Aug;60(125):1169-73. doi: 10.5754/hge12902.

PMID:
23803380
2.

Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.

Sun XD, Liu XE, Huang DS.

Oncol Rep. 2013 Jun;29(6):2401-7. doi: 10.3892/or.2013.2385. Epub 2013 Apr 4.

PMID:
23563640
3.

Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway.

Xu W, Wang Z, Zhang W, Qian K, Li H, Kong D, Li Y, Tang Y.

Cancer Lett. 2015 Jan 28;356(2 Pt B):613-27. doi: 10.1016/j.canlet.2014.10.008. Epub 2014 Oct 8.

PMID:
25305448
4.

The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cells.

Xu D, Allsop SA, Witherspoon SM, Snider JL, Yeh JJ, Fiordalisi JJ, White CD, Williams D, Cox AD, Baines AT.

Carcinogenesis. 2011 Apr;32(4):488-95. doi: 10.1093/carcin/bgr007. Epub 2011 Jan 24.

5.

Hedgehog signaling regulates hypoxia induced epithelial to mesenchymal transition and invasion in pancreatic cancer cells via a ligand-independent manner.

Lei J, Ma J, Ma Q, Li X, Liu H, Xu Q, Duan W, Sun Q, Xu J, Wu Z, Wu E.

Mol Cancer. 2013 Jun 20;12:66. doi: 10.1186/1476-4598-12-66.

6.

Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.

Heinrich EL, Lee W, Lu J, Lowy AM, Kim J.

J Transl Med. 2012 Apr 2;10:68. doi: 10.1186/1479-5876-10-68.

7.

[Experimental study of the function of nuclear factor-κB-dependent epithelial to mesenchymal transition in pancreatic cancer cells under hypoxic conditions].

Cheng ZX, Sun B, Wang SJ, Zhou HX, Jia G, Kong R, Wang G, Jiang HC.

Zhonghua Wai Ke Za Zhi. 2012 May;50(5):446-51. Chinese.

PMID:
22883954
8.

Expression profiling of the influence of RAS mutants on the TGFB1-induced phenotype of the pancreatic cancer cell line PANC-1.

Fensterer H, Giehl K, Buchholz M, Ellenrieder V, Buck A, Kestler HA, Adler G, Gierschik P, Gress TM.

Genes Chromosomes Cancer. 2004 Mar;39(3):224-35.

PMID:
14732924
9.

[Simultaneous inhibition of XIAP and survivin expression on EMT and invasion of human pancreatic cancer cells].

Zai H, Yi X, Li Y, Jiang C, Lu X.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012 Sep;37(9):883-8. Chinese.

10.

[Regulatory mechanisms of Hedgehog signaling pathway for epithelial-mesenchymal transition in pancreatic cancer cells].

Xie K, Hao K, Tian XD, Chang ZG, Qin CF, Yang YM.

Zhonghua Yi Xue Za Zhi. 2011 Nov 29;91(44):3103-6. Chinese.

PMID:
22340649
11.
12.
13.

miR-208-induced epithelial to mesenchymal transition of pancreatic cancer cells promotes cell metastasis and invasion.

Liu A, Shao C, Jin G, Liu R, Hao J, Song B, Ouyang L, Hu X.

Cell Biochem Biophys. 2014 Jun;69(2):341-6. doi: 10.1007/s12013-013-9805-3.

PMID:
24604208
14.

Combined silencing of K-ras and Akt2 oncogenes achieves synergistic effects in inhibiting pancreatic cancer cell growth in vitro and in vivo.

Shi XH, Liang ZY, Ren XY, Liu TH.

Cancer Gene Ther. 2009 Mar;16(3):227-36. doi: 10.1038/cgt.2008.82. Epub 2008 Oct 24.

PMID:
18949011
15.

Rottlerin suppresses growth of human pancreatic tumors in nude mice, and pancreatic cancer cells isolated from Kras(G12D) mice.

Huang M, Tang SN, Upadhyay G, Marsh JL, Jackman CP, Srivastava RK, Shankar S.

Cancer Lett. 2014 Oct 10;353(1):32-40. doi: 10.1016/j.canlet.2014.06.021. Epub 2014 Jul 19.

PMID:
25050737
16.

Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice.

Zhao M, Tang SN, Marsh JL, Shankar S, Srivastava RK.

Cancer Lett. 2013 Sep 1;337(2):210-7. doi: 10.1016/j.canlet.2013.05.009. Epub 2013 May 16.

PMID:
23684930
17.

K-RAS mutant pancreatic tumors show higher sensitivity to MEK than to PI3K inhibition in vivo.

Hofmann I, Weiss A, Elain G, Schwaederle M, Sterker D, Romanet V, Schmelzle T, Lai A, Brachmann SM, Bentires-Alj M, Roberts TM, Sellers WR, Hofmann F, Maira SM.

PLoS One. 2012;7(8):e44146. doi: 10.1371/journal.pone.0044146. Epub 2012 Aug 31.

19.

Regulation of pancreatic cancer growth by superoxide.

Du J, Nelson ES, Simons AL, Olney KE, Moser JC, Schrock HE, Wagner BA, Buettner GR, Smith BJ, Teoh ML, Tsao MS, Cullen JJ.

Mol Carcinog. 2013 Jul;52(7):555-67. doi: 10.1002/mc.21891. Epub 2012 Mar 5.

20.

Supplemental Content

Support Center